Symbols / PEN Stock $333.58 +0.41% Penumbra, Inc.
PEN (Stock) Chart
About
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Stock Fundamentals
Scroll to Statements| Market Cap | 13.09B | Enterprise Value | 12.71B | Income | 177.69M | Sales | 1.40B | Book/sh | 36.39 | Cash/sh | 13.88 |
| Dividend Yield | — | Payout | 0.00% | Employees | 4700 | IPO | — | P/E | 73.80 | Forward P/E | 52.30 |
| PEG | 0.74 | P/S | 9.33 | P/B | 9.17 | P/C | — | EV/EBITDA | 61.55 | EV/Sales | 9.06 |
| Quick Ratio | 4.01 | Current Ratio | 6.64 | Debt/Eq | 15.39 | LT Debt/Eq | — | EPS (ttm) | 4.52 | EPS next Y | 6.38 |
| EPS Growth | 38.30% | Revenue Growth | 22.10% | Earnings | 2026-04-24 | ROA | 7.04% | ROE | 13.78% | ROIC | — |
| Gross Margin | 67.14% | Oper. Margin | 15.37% | Profit Margin | 12.66% | Shs Outstand | 39.24M | Shs Float | 38.05M | Short Float | 8.40% |
| Short Ratio | 3.75 | Short Interest | — | 52W High | 362.41 | 52W Low | 221.26 | Beta | 0.84 | Avg Volume | 719.29K |
| Volume | 371.41K | Target Price | $365.79 | Recom | Hold | Prev Close | $332.21 | Price | $333.57 | Change | 0.41% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-26 | main | Evercore ISI Group | Outperform → Outperform | $360 |
| 2026-01-20 | down | RBC Capital | Outperform → Sector Perform | $374 |
| 2026-01-20 | down | Canaccord Genuity | Buy → Hold | $374 |
| 2026-01-16 | down | Jefferies | Buy → Hold | $374 |
| 2026-01-16 | down | Needham | Buy → Hold | — |
| 2026-01-16 | down | Citigroup | Buy → Neutral | $374 |
| 2026-01-16 | down | Leerink Partners | Outperform → Market Perform | $374 |
| 2026-01-16 | down | Baird | Outperform → Neutral | $374 |
| 2026-01-16 | down | BTIG | Buy → Neutral | $349 |
| 2026-01-16 | down | Truist Securities | Buy → Hold | $374 |
| 2026-01-15 | down | Wells Fargo | Overweight → Equal-Weight | $374 |
| 2026-01-15 | down | William Blair | Outperform → Market Perform | — |
| 2026-01-05 | main | B of A Securities | Buy → Buy | $370 |
| 2025-12-18 | main | Truist Securities | Buy → Buy | $370 |
| 2025-12-18 | up | JP Morgan | Neutral → Overweight | $370 |
| 2025-12-17 | main | Canaccord Genuity | Buy → Buy | $359 |
| 2025-12-17 | main | Needham | Buy → Buy | $388 |
| 2025-12-11 | up | Citigroup | Neutral → Buy | $350 |
| 2025-11-06 | main | JP Morgan | Neutral → Neutral | $275 |
| 2025-11-06 | main | Canaccord Genuity | Buy → Buy | $355 |
News
RSS: Latest PEN news- PEN Stock Price, Quote & Chart | PENUMBRA INC (NYSE:PEN) - ChartMill Mon, 20 Apr 2026 07
- Why Penumbra’s Stock Is Sinking Again Today - TipRanks hu, 23 Apr 2026 12
- Why Penumbra (PEN) Stock Is Trading Up Today - Yahoo Finance hu, 15 Jan 2026 08
- Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Contender With 10% Upside Potential - DirectorsTalk Interviews Mon, 20 Apr 2026 09
- Penumbra (PEN) Deep Dive | Q4 2025: Profit Exceeds Views - Dark Pool - Cổng thông tin điện tử Tỉnh Sơn La hu, 23 Apr 2026 01
- 2 Reasons to Avoid PEN and 1 Stock to Buy Instead - StockStory Sun, 29 Mar 2026 07
- Insider Sale: Director at $PEN Sells 100 Shares - Quiver Quantitative ue, 07 Apr 2026 00
- Board backs Boston Scientific acquisition of Penumbra (PEN); Special Meeting May 6, 2026 - Stock Titan Fri, 17 Apr 2026 20
- Yuba Water Agency provides update on recent penstock rupture, shares injured contract employee is in stable condition - YubaNet ue, 17 Feb 2026 08
- 3 Reasons to Sell PEN and 1 Stock to Buy Instead - Yahoo Finance ue, 20 Jan 2026 08
- $PEN stock is up 12% today. Here's what we see in our data. - Quiver Quantitative hu, 15 Jan 2026 08
- Penumbra (PEN) Stock Trades Up, Here Is Why - Yahoo Finance Wed, 08 Oct 2025 07
- Why Penumbra (PEN) Shares Are Falling Today - Yahoo Finance ue, 28 Oct 2025 07
- Penumbra (PEN) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance Wed, 07 Jan 2026 08
- CLPBY vs. PEN: Which Stock Is the Better Value Option? - Yahoo Finance Mon, 12 Jan 2026 08
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,403.66
+17.50%
|
1,194.62
+12.86%
|
1,058.52
+24.95%
|
847.13
|
| Operating Revenue |
|
1,403.66
+17.50%
|
1,194.62
+12.86%
|
1,058.52
+24.95%
|
847.13
|
| Cost Of Revenue |
|
461.23
+4.92%
|
439.62
+16.96%
|
375.88
+20.50%
|
311.93
|
| Reconciled Cost Of Revenue |
|
461.23
+4.92%
|
439.62
+16.96%
|
375.88
+20.50%
|
311.93
|
| Gross Profit |
|
942.44
+24.83%
|
755.00
+10.60%
|
682.64
+27.55%
|
535.21
|
| Operating Expense |
|
753.19
+12.62%
|
668.77
+13.18%
|
590.88
+11.67%
|
529.12
|
| Research And Development |
|
89.77
-5.29%
|
94.78
+12.27%
|
84.42
+6.32%
|
79.41
|
| Selling General And Administration |
|
663.42
+15.58%
|
573.99
+13.33%
|
506.45
+12.62%
|
449.72
|
| Total Expenses |
|
1,214.42
+9.57%
|
1,108.39
+14.65%
|
966.76
+14.95%
|
841.05
|
| Operating Income |
|
189.25
+119.49%
|
86.22
-6.04%
|
91.77
+1408.81%
|
6.08
|
| Total Operating Income As Reported |
|
189.25
+1939.54%
|
9.28
-87.38%
|
73.55
+1109.32%
|
6.08
|
| EBITDA |
|
223.91
+386.87%
|
45.99
-57.67%
|
108.65
+262.61%
|
29.96
|
| Normalized EBITDA |
|
223.91
+82.14%
|
122.93
-3.10%
|
126.86
+323.41%
|
29.96
|
| Reconciled Depreciation |
|
17.47
-26.29%
|
23.70
-13.04%
|
27.26
+12.07%
|
24.32
|
| EBIT |
|
206.44
+826.26%
|
22.29
-72.62%
|
81.39
+1342.81%
|
5.64
|
| Total Unusual Items |
|
0.00
+100.00%
|
-76.94
-322.43%
|
-18.21
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
0.00
+100.00%
|
-76.94
-322.43%
|
-18.21
|
0.00
|
| Special Income Charges |
|
0.00
+100.00%
|
-76.94
-322.43%
|
-18.21
|
0.00
|
| Other Special Charges |
|
—
|
—
|
18.21
|
—
|
| Impairment Of Capital Assets |
|
—
|
76.94
|
0.00
|
0.00
|
| Write Off |
|
0.00
|
—
|
—
|
—
|
| Net Income |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Pretax Income |
|
205.12
+882.92%
|
20.87
-73.80%
|
79.65
+1946.51%
|
3.89
|
| Net Non Operating Interest Income Expense |
|
14.98
+22.09%
|
12.27
+141.29%
|
5.09
+3612.41%
|
0.14
|
| Interest Expense Non Operating |
|
1.31
-7.55%
|
1.42
-18.46%
|
1.74
-0.57%
|
1.75
|
| Net Interest Income |
|
14.98
+22.09%
|
12.27
+141.29%
|
5.09
+3612.41%
|
0.14
|
| Interest Expense |
|
1.31
-7.55%
|
1.42
-18.46%
|
1.74
-0.57%
|
1.75
|
| Interest Income Non Operating |
|
16.29
+19.02%
|
13.69
+100.59%
|
6.83
+261.88%
|
1.89
|
| Interest Income |
|
16.29
+19.02%
|
13.69
+100.59%
|
6.83
+261.88%
|
1.89
|
| Other Income Expense |
|
0.89
+101.15%
|
-77.63
-351.27%
|
-17.20
-639.24%
|
-2.33
|
| Other Non Operating Income Expenses |
|
0.89
+230.94%
|
-0.68
-167.32%
|
1.01
+143.53%
|
-2.33
|
| Tax Provision |
|
27.44
+300.15%
|
6.86
+160.66%
|
-11.30
-291.79%
|
5.89
|
| Tax Rate For Calcs |
|
0.00
-59.27%
|
0.00
+56.67%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
+100.00%
|
-25.31
-561.80%
|
-3.83
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Net Income From Continuing And Discontinued Operation |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Net Income Continuous Operations |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Minority Interests |
|
—
|
—
|
0.00
|
0.00
|
| Normalized Income |
|
177.69
+170.69%
|
65.64
-37.69%
|
105.34
+5361.93%
|
-2.00
|
| Net Income Common Stockholders |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Diluted EPS |
|
4.52
+1155.56%
|
0.36
-84.48%
|
2.32
+4740.00%
|
-0.05
|
| Basic EPS |
|
4.57
+1169.44%
|
0.36
-84.81%
|
2.37
+4840.00%
|
-0.05
|
| Basic Average Shares |
|
38.92
+0.74%
|
38.63
+0.61%
|
38.40
+1.48%
|
37.84
|
| Diluted Average Shares |
|
39.29
+0.06%
|
39.27
+0.13%
|
39.22
+3.63%
|
37.84
|
| Diluted NI Availto Com Stockholders |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
1,556.31
|
| Current Assets |
|
915.40
|
| Cash Cash Equivalents And Short Term Investments |
|
289.19
|
| Cash And Cash Equivalents |
|
167.49
|
| Other Short Term Investments |
|
121.70
|
| Receivables |
|
201.77
|
| Accounts Receivable |
|
201.77
|
| Gross Accounts Receivable |
|
204.94
|
| Allowance For Doubtful Accounts Receivable |
|
-3.17
|
| Inventory |
|
388.02
|
| Raw Materials |
|
119.51
|
| Work In Process |
|
34.49
|
| Finished Goods |
|
234.02
|
| Prepaid Assets |
|
—
|
| Other Current Assets |
|
36.42
|
| Total Non Current Assets |
|
640.90
|
| Net PPE |
|
280.50
|
| Gross PPE |
|
332.25
|
| Accumulated Depreciation |
|
-51.75
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
79.63
|
| Construction In Progress |
|
3.54
|
| Other Properties |
|
219.85
|
| Leases |
|
29.24
|
| Goodwill And Other Intangible Assets |
|
249.37
|
| Goodwill |
|
166.27
|
| Other Intangible Assets |
|
83.09
|
| Non Current Deferred Assets |
|
85.16
|
| Non Current Deferred Taxes Assets |
|
85.16
|
| Other Non Current Assets |
|
25.88
|
| Total Liabilities Net Minority Interest |
|
377.36
|
| Current Liabilities |
|
151.14
|
| Payables And Accrued Expenses |
|
130.72
|
| Payables |
|
27.16
|
| Accounts Payable |
|
27.16
|
| Current Accrued Expenses |
|
103.57
|
| Current Debt And Capital Lease Obligation |
|
13.43
|
| Current Capital Lease Obligation |
|
13.43
|
| Current Deferred Liabilities |
|
6.99
|
| Current Deferred Revenue |
|
6.99
|
| Total Non Current Liabilities Net Minority Interest |
|
226.22
|
| Long Term Debt And Capital Lease Obligation |
|
220.91
|
| Long Term Capital Lease Obligation |
|
220.91
|
| Other Non Current Liabilities |
|
5.31
|
| Stockholders Equity |
|
1,178.94
|
| Common Stock Equity |
|
1,178.94
|
| Capital Stock |
|
0.04
|
| Common Stock |
|
0.04
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
38.68
|
| Ordinary Shares Number |
|
38.68
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
1,047.20
|
| Retained Earnings |
|
134.86
|
| Gains Losses Not Affecting Retained Earnings |
|
-3.15
|
| Minority Interest |
|
—
|
| Other Equity Adjustments |
|
-3.15
|
| Total Equity Gross Minority Interest |
|
1,178.94
|
| Total Capitalization |
|
1,178.94
|
| Working Capital |
|
764.26
|
| Invested Capital |
|
1,178.94
|
| Total Debt |
|
234.34
|
| Capital Lease Obligations |
|
234.34
|
| Net Tangible Assets |
|
929.58
|
| Tangible Book Value |
|
929.58
|
| Current Provisions |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
238.66
+41.66%
|
168.48
+73.10%
|
97.33
+274.87%
|
-55.66
|
| Cash Flow From Continuing Operating Activities |
|
238.66
+41.66%
|
168.48
+73.10%
|
97.33
+274.87%
|
-55.66
|
| Net Income From Continuing Operations |
|
177.69
+1168.11%
|
14.01
-84.59%
|
90.95
+4643.16%
|
-2.00
|
| Depreciation Amortization Depletion |
|
17.47
-26.29%
|
23.70
-13.04%
|
27.26
+12.07%
|
24.32
|
| Depreciation And Amortization |
|
17.47
-26.29%
|
23.70
-13.04%
|
27.26
+12.07%
|
24.32
|
| Other Non Cash Items |
|
0.20
-95.03%
|
4.12
-79.95%
|
20.55
+1513.27%
|
1.27
|
| Stock Based Compensation |
|
59.21
+28.27%
|
46.16
-8.62%
|
50.52
+35.15%
|
37.38
|
| Asset Impairment Charge |
|
5.77
-95.22%
|
120.60
+1845.81%
|
6.20
+79.91%
|
3.44
|
| Deferred Tax |
|
21.03
+228.73%
|
-16.34
+14.28%
|
-19.06
-1407.34%
|
1.46
|
| Deferred Income Tax |
|
21.03
+228.73%
|
-16.34
+14.28%
|
-19.06
-1407.34%
|
1.46
|
| Change In Working Capital |
|
-42.72
-79.63%
|
-23.78
+69.93%
|
-79.08
+34.93%
|
-121.53
|
| Change In Receivables |
|
-19.51
-173.37%
|
26.60
+10098.87%
|
-0.27
+99.62%
|
-69.86
|
| Changes In Account Receivables |
|
-19.51
-173.37%
|
26.60
+10098.87%
|
-0.27
+99.62%
|
-69.86
|
| Change In Inventory |
|
-26.48
+59.67%
|
-65.66
+3.03%
|
-67.71
+9.27%
|
-74.63
|
| Change In Prepaid Assets |
|
-12.70
-330.70%
|
-2.95
+84.41%
|
-18.91
-1428.62%
|
-1.24
|
| Change In Payables And Accrued Expense |
|
15.98
-12.35%
|
18.23
+149.10%
|
7.32
-69.42%
|
23.93
|
| Change In Accrued Expense |
|
12.91
-8.16%
|
14.06
+125.96%
|
6.22
-40.99%
|
10.54
|
| Change In Payable |
|
3.07
-26.49%
|
4.17
+280.31%
|
1.10
-91.80%
|
13.38
|
| Change In Account Payable |
|
3.07
-26.49%
|
4.17
+280.31%
|
1.10
-91.80%
|
13.38
|
| Change In Other Working Capital |
|
—
|
—
|
0.48
+83.65%
|
0.26
|
| Investing Cash Flow |
|
-404.59
-621.22%
|
77.62
+582.86%
|
-16.08
-129.34%
|
54.79
|
| Cash Flow From Continuing Investing Activities |
|
-404.59
-621.22%
|
77.62
+582.86%
|
-16.08
-129.34%
|
54.79
|
| Net PPE Purchase And Sale |
|
-63.73
-200.86%
|
-21.18
-39.24%
|
-15.21
+21.17%
|
-19.30
|
| Purchase Of PPE |
|
-63.73
-200.86%
|
-21.18
-39.24%
|
-15.21
+21.17%
|
-19.30
|
| Capital Expenditure |
|
-63.73
-200.86%
|
-21.18
-39.24%
|
-15.21
+21.17%
|
-19.30
|
| Net Investment Purchase And Sale |
|
-340.86
-448.86%
|
97.71
+15532.96%
|
0.62
-99.16%
|
74.09
|
| Purchase Of Investment |
|
-355.74
-980.94%
|
-32.91
+59.84%
|
-81.94
|
0.00
|
| Sale Of Investment |
|
14.88
-88.61%
|
130.62
+58.20%
|
82.56
+11.44%
|
74.09
|
| Net Business Purchase And Sale |
|
—
|
—
|
-0.99
|
0.00
|
| Purchase Of Business |
|
—
|
—
|
-0.99
|
0.00
|
| Net Other Investing Changes |
|
—
|
1.10
+173.92%
|
-1.49
|
—
|
| Financing Cash Flow |
|
26.53
+130.49%
|
-87.01
-636.97%
|
16.20
+39.42%
|
11.62
|
| Cash Flow From Continuing Financing Activities |
|
26.53
+130.49%
|
-87.01
-636.97%
|
16.20
+39.42%
|
11.62
|
| Net Issuance Payments Of Debt |
|
-2.48
-9.18%
|
-2.28
-14.89%
|
-1.98
-13.14%
|
-1.75
|
| Repayment Of Debt |
|
-2.48
-9.18%
|
-2.28
-14.89%
|
-1.98
-13.14%
|
-1.75
|
| Long Term Debt Payments |
|
-2.48
-9.18%
|
-2.28
-14.89%
|
-1.98
-13.14%
|
-1.75
|
| Net Long Term Debt Issuance |
|
-2.48
-9.18%
|
-2.28
-14.89%
|
-1.98
-13.14%
|
-1.75
|
| Net Common Stock Issuance |
|
0.00
+100.00%
|
-100.39
|
0.00
|
0.00
|
| Common Stock Payments |
|
0.00
+100.00%
|
-100.39
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
0.00
+100.00%
|
-100.39
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
31.82
+85.27%
|
17.17
-15.87%
|
20.41
-5.28%
|
21.55
|
| Net Other Financing Charges |
|
-2.80
-84.71%
|
-1.52
+31.94%
|
-2.23
+72.75%
|
-8.18
|
| Changes In Cash |
|
-139.40
-187.62%
|
159.10
+63.25%
|
97.46
+806.52%
|
10.75
|
| Effect Of Exchange Rate Changes |
|
1.89
+186.57%
|
-2.18
-1398.21%
|
0.17
+161.76%
|
-0.27
|
| Beginning Cash Position |
|
324.40
+93.69%
|
167.49
+139.75%
|
69.86
+17.65%
|
59.38
|
| End Cash Position |
|
186.90
-42.39%
|
324.40
+93.69%
|
167.49
+139.75%
|
69.86
|
| Free Cash Flow |
|
174.93
+18.76%
|
147.30
+79.37%
|
82.12
+209.55%
|
-74.96
|
| Income Tax Paid Supplemental Data |
|
—
|
20.67
+215.30%
|
6.56
+124.63%
|
2.92
|
| Common Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Sale Of Business |
|
—
|
—
|
0.00
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-06 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-17 View
- 42026-03-04 View
- 10-K2026-02-25 View
- 8-K2026-02-25 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-02-18 View
- 42026-01-16 View
- 8-K2026-01-15 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|